Sterling Pharma USA

Sterling Pharma USA is the U.S. operating entity of Sterling Pharma Solutions, a pharmaceutical development and manufacturing company focused primarily on small molecule active pharmaceutical ingredient development and manufacturing. The Cary, North Carolina site supports products from preclinical development through Phase 2 and offers cGMP API manufacturing, GLP analytical services, and capabilities for high-value, low-volume and controlled-substance compounds. Across the broader Sterling network, the company also supports antibody-drug conjugate and peptide-related development and manufacturing services. Rather than developing its own therapeutic pipeline, Sterling acts as a contract partner to biotech and pharmaceutical companies from early development through commercial supply.